The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications

Journal of Clinical Apheresis

Volumn 25, Issue 4, 2010, Pages 195-201

  Şentürk, Evren ^a   Esen, Figen ^a   Özcan, Perihan E ^a   Rifai, Kinan ^b   Pinarbaşi, Binnur ^a   Çakar, Nahit ^a   Telci, Lutfi ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Artificial liver support systems; Fractionated plasma separation and adsorption; Liver failure

Indexed keywords

AMMONIA; BILIRUBIN; CITRIC ACID; CREATININE;

ADOLESCENT; ADULT; AGED; AMMONIA BLOOD LEVEL; ANTICOAGULATION; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PH; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DETOXIFICATION; FEMALE; FRACTIONATED PLASMA SEPARATION AND ADSORPTION SYSTEM; HEMODIALYSIS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; SCHOOL CHILD; SURVIVAL RATE; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BLOOD; CHEMICAL FRACTIONATION; CHILD; CITRIC ACID; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; RENAL DIALYSIS; SORPTION DETOXIFICATION; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956274872     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20238     Document Type: Article

References (28)

1. Rifai K, Tetta C, Ronco C. Liver support with fractionated plasma separation and adsorption and Prometheus®. In: Vincent JL, editor. 2008 Yearbook of Intensive Care and Emergency Medicine. Springer: Berlin, Heidelberg. 2008. pp 777-785.
2. Demetriou AA, Brown RS Jr., Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS II, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-667. (Pubitemid 38525637)
3. Knell AJ, Dukes DC. Dialysis procedures in acute liver coma. Lancet 1976;2:402-403.
4. Desmet VJ, De Groote J, Van Damme B. Acute hepatocellular failure. A study of 17 patients treated with exchange transfusion. Hum Pathol 1972;3:167-182.
5. Freeman JG, Matthewson K, Record CO. Plasmapheresis in acute liver failure. Int J Artif Organs 1986;9:433-438.
6. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
7. Kamohara Y, Rozga J, Demetriou AA. Artificial liver: review and Cedars-Sinai experience. J Hepatobiliary Pancreat Surg 1998;5:273-285. (Pubitemid 128662593)
8. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996;16:415-425. (Pubitemid 27074783)
9. Stockmann H, Hiemstra CA, Marquet RL, Ijzermans JN. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg 2000;231:460-470. (Pubitemid 30185851)
10. Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005;43:451-457.
11. Rifai K, Manns MP. Clinical experience with Prometheus. Ther Apher Dial 2006;10:132-137.
12. Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R. Successful treatment of refractory cerebral edema in cocaine-induced fulminant hepatic failure using a new high efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 2003;115:599-603. (Pubitemid 37158290)
13. Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y. Detoxifying capacity and kinetics of Prometheus - a new extracorporeal system for the treatment of liver failure. Blood Purif 2005;23:349-358. (Pubitemid 41197044)
14. Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M. Results of treatment of acute liver failure patients with use of the Prometheus FPSA system. Transplant Proc 2009;41:3079-3081.
15. Skwarek A, Grodzicki M, Nyckowski P, Kotulski M, Zieniewicz K, Michalowicz B, Patkowski W, Grzelak I, Paczkowska A, Giercuszkiewicz D, Sanko-Resmer J, Paczek L, Krawczyk M. The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc 2006;38:209-211.
16. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445. (Pubitemid 19192181)
17. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary centers in the United States. Ann Intern Med 2002;137:947-954.
18. Oppert M, Rademacher S, Petrasch K, Jörres A. Extracorporeal liver support therapy with Prometheus in patients with liver failure in the ICU. Ther Apher Dial 2009;13:426-430.
19. Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, Schoenhofen M. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999;23:81-86. (Pubitemid 29047501)
20. Rifai K, Ernst T, Kretschmer U, Hafer C, Haller H, Manns MP, Fliser D. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005;23:298-302. (Pubitemid 41327801)
21. Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute on chronic liver failure. Crit Care 2006;10:R169. (Pubitemid 46211022)
22. Faenza S, Baraldi O, Bernardi M, Bolondi L, Coli L, Cucchetti A, Donati G, Gozzetti F, Lauro A, Mancini E, Pinna AD, Piscaglia F, Rasciti L, Ravaioli M, Ruggeri G, Santoro A, Stefoni S. MARS and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008;40:1169-1171. (Pubitemid 351794319)
23. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29;648-653. (Pubitemid 29109575)
24. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Effects of molecular adsorbent recirculating system and Prometheus on systemic haemodynamics and vasoactive agents in patients with acute on chronic alcoholic liver failure. Crit Care 2006;10:R108. (Pubitemid 47086893)
25. Dethloff T, Tofteng F, Frederiksen HJ, Hojskov M, Hansen BA, Larsen FS. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol 2008;14:2065-2071. (Pubitemid 351795828)
26. Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus. Artif Organs 2009;34:84-88.
27. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003;31:2450-2455. (Pubitemid 37281728)
28. Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol 2006;12:940-944.